 |
The Journal of Neuroscience, October 15, 2003, 23(28):9403-9408
Previous Article | Next Article 
BRIEF COMMUNICATION
Forebrain-Specific Neuronal Inhibition of Nuclear Factor- B Activity Leads to Loss of Neuroprotection
Valérie Fridmacher,1 *
Barbara Kaltschmidt,3 *
Bertrand Goudeau,1
Delphine Ndiaye,1
Francesco Mattia Rossi,2
Julia Pfeiffer,3
Christian Kaltschmidt,3
Alain Israël,1 and
Sylvie Mémet1
1Unité de Biologie Moléculaire de l'Expression Génique, Unité de Recherche Associée Centre National de la Recherche Scientifique 2582, 2Unité Récepteurs et Cognition, Centre National de la Recherche Scientifique Unité de Recherche Associée 2182, Institut Pasteur, 75724 Paris Cedex 15, France, and 3University of Witten/Herdecke Institut für Neurobiochemie, 58448 Witten, Germany
The transcription factor Rel/nuclear factor (NF)- B is known for its fundamental role in regulating immune and inflammatory responses. In the brain, constitutive NF- B activity has been detected exclusively in neurons, and a large diversity of stimuli have been reported to induce NF- B activity. Yet the function of this transcription factor in the nervous system remains unclear, and its role in neuroprotection or neurodegeneration is open to debate. Recently it was suggested that B-driven gene expression in neurons is controlled by Sp1-like factors. To clarify such controversy, we have characterized here a novel mouse model in which the entire NF- B-dependent transcriptional response is abolished in the forebrain. Calcium-calmodulin-dependent kinase II promoter-driven tetracycline transactivator was used for regulated expression of a transdominant negative mutant of inhibitor B (super-repressor) together with a green fluorescent protein tracer. Inhibition of expression of a B-dependent lacZ transgene was shown in triple transgenic mice, which correlated with the loss of B-specific DNA binding. In transgenic organotypic hippocampal slice cultures, expression of the super-repressor led to strong cell death after neurotoxic insults. These data demonstrate for the first time that neuron-restricted ablation of NF- B-driven gene expression increases neurodegeneration. This might lead to the path for new treatments of neurodegenerative diseases.
Key words: transcription factor NF- B; brain; tetracycline; neuroprotection; organotypic hippocampal slice cultures; kainate; ferrous sulfate; transgenic mice
Received Feb 6, 2003;
revised August 20, 2003;
accepted August 28, 2003.
This article has been cited by other articles:

|
 |

|
 |
 
B. Kaltschmidt and C. Kaltschmidt
NF-{kappa}B in the Nervous System
Cold Spring Harb Perspect Biol,
September 1, 2009;
1(3):
a001271 - a001271.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. H.A. Nijboer, C. J. Heijnen, F. Groenendaal, M. J. May, F. van Bel, and A. Kavelaars
Strong Neuroprotection by Inhibition of NF-{kappa}B After Neonatal Hypoxia-Ischemia Involves Apoptotic Mechanisms but Is Independent of Cytokines
Stroke,
July 1, 2008;
39(7):
2129 - 2137.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. J. Edenberg, X. Xuei, L. F. Wetherill, L. Bierut, K. Bucholz, D. M. Dick, V. Hesselbrock, S. Kuperman, B. Porjesz, M. A. Schuckit, et al.
Association of NFKB1, which encodes a subunit of the transcription factor NF-{kappa}B, with alcohol dependence
Hum. Mol. Genet.,
April 1, 2008;
17(7):
963 - 970.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Taoufik, S. Valable, G. J. Muller, M. L. Roberts, D. Divoux, A. Tinel, A. Voulgari-Kokota, V. Tseveleki, F. Altruda, H. Lassmann, et al.
FLIPL Protects Neurons against In Vivo Ischemia and In Vitro Glucose Deprivation-Induced Cell Death
J. Neurosci.,
June 20, 2007;
27(25):
6633 - 6646.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Inta, S. Paxian, I. Maegele, W. Zhang, M. Pizzi, P. Spano, I. Sarnico, S. Muhammad, O. Herrmann, D. Inta, et al.
Bim and Noxa Are Candidates to Mediate the Deleterious Effect of the NF-{kappa}B Subunit RelA in Cerebral Ischemia
J. Neurosci.,
December 13, 2006;
26(50):
12896 - 12903.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. O'Mahony, J. Raber, M. Montano, E. Foehr, V. Han, S.-m. Lu, H. Kwon, A. LeFevour, S. Chakraborty-Sett, and W. C. Greene
NF-{kappa}B/Rel Regulates Inhibitory and Excitatory Neuronal Function and Synaptic Plasticity.
Mol. Cell. Biol.,
October 1, 2006;
26(19):
7283 - 7298.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Navarrete, R. Sancho, F. J. Caballero, F. Pollastro, B. L. Fiebich, O. Sterner, G. Appendino, and E. Munoz
Basiliolides, a Class of Tetracyclic C19 Dilactones from Thapsia garganica, Release Ca2+ from the Endoplasmic Reticulum and Regulate the Activity of the Transcription Factors Nuclear Factor of Activated T Cells, Nuclear Factor-{kappa}B, and Activator Protein 1 in T Lymphocytes
J. Pharmacol. Exp. Ther.,
October 1, 2006;
319(1):
422 - 430.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Qiu, F. Norflus, B. Singh, M. K. Swindell, R. Buzescu, M. Bejarano, R. Chopra, B. Zucker, C. L. Benn, D. P. DiRocco, et al.
Sp1 Is Up-regulated in Cellular and Transgenic Models of Huntington Disease, and Its Reduction Is Neuroprotective
J. Biol. Chem.,
June 16, 2006;
281(24):
16672 - 16680.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Kaltschmidt, D. Ndiaye, M. Korte, S. Pothion, L. Arbibe, M. Prullage, J. Pfeiffer, A. Lindecke, V. Staiger, A. Israel, et al.
NF-{kappa}B Regulates Spatial Memory Formation and Synaptic Plasticity through Protein Kinase A/CREB Signaling
Mol. Cell. Biol.,
April 15, 2006;
26(8):
2936 - 2946.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Tao, D. Yan, Q. Yang, R. Zeng, and Y. Wang
Low K+ Promotes NF-{kappa}B/DNA Binding in Neuronal Apoptosis Induced by K+ Loss
Mol. Cell. Biol.,
February 1, 2006;
26(3):
1038 - 1050.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Chen, Y. Zhou, S. Mueller-Steiner, L.-F. Chen, H. Kwon, S. Yi, L. Mucke, and L. Gan
SIRT1 Protects against Microglia-dependent Amyloid-{beta} Toxicity through Inhibiting NF-{kappa}B Signaling
J. Biol. Chem.,
December 2, 2005;
280(48):
40364 - 40374.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Bourteele, K. Oesterle, S. Pleschka, G. Unterstab, C. Ehrhardt, T. Wolff, S. Ludwig, and O. Planz
Constitutive Activation of the Transcription Factor NF-{kappa}B Results in Impaired Borna Disease Virus Replication
J. Virol.,
May 15, 2005;
79(10):
6043 - 6051.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Gutierrez, V. A. Hale, X. Dolcet, and A. Davies
NF-{kappa}B signalling regulates the growth of neural processes in the developing PNS and CNS
Development,
April 1, 2005;
132(7):
1713 - 1726.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Jung, M. B. Gatch, and J. W. Simpkins
Estrogen Neuroprotection Against the Neurotoxic Effects of Ethanol Withdrawal: Potential Mechanisms
Experimental Biology and Medicine,
January 1, 2005;
230(1):
8 - 22.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Potrovita, W. Zhang, L. Burkly, K. Hahm, J. Lincecum, M. Z. Wang, M. H. Maurer, M. Rossner, A. Schneider, and M. Schwaninger
Tumor Necrosis Factor-Like Weak Inducer of Apoptosis-Induced Neurodegeneration
J. Neurosci.,
September 22, 2004;
24(38):
8237 - 8244.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Marchetti, M. Klein, K. Schlett, K. Pfizenmaier, and U. L. M. Eisel
Tumor Necrosis Factor (TNF)-mediated Neuroprotection against Glutamate-induced Excitotoxicity Is Enhanced by N-Methyl-D-aspartate Receptor Activation: ESSENTIAL ROLE OF A TNF RECEPTOR 2-MEDIATED PHOSPHATIDYLINOSITOL 3-KINASE-DEPENDENT NF-{kappa}B PATHWAY
J. Biol. Chem.,
July 30, 2004;
279(31):
32869 - 32881.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|